We wished to determine whether overexpression of the NF-κB inhibitor IκBα could modulate the severity of acute and prolonged pneumonia-induced lung injury in a series of prospective randomized animal studies. The gene discussed is NFKB1; the disease is susceptibility to pneumonia measurement.